194 related articles for article (PubMed ID: 34445161)
21. Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations.
Bousquet M; Noirot C; Accadbled F; Sales de Gauzy J; Castex MP; Brousset P; Gomez-Brouchet A
Ann Oncol; 2016 Apr; 27(4):738-44. PubMed ID: 26787232
[TBL] [Abstract][Full Text] [Related]
22. Genomic Alterations in Human Papillomavirus-Positive and -Negative Conjunctival Squamous Cell Carcinomas.
Ramberg I; Vieira FG; Toft PB; von Buchwald C; Funding M; Nielsen FC; Heegaard S
Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):11. PubMed ID: 34779821
[TBL] [Abstract][Full Text] [Related]
23. Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas.
Chan MP; Plouffe KR; Liu CJ; Palanisamy N; Carskadon S; Zhao L; Nazarian RM; Durham AB; Johnson TM; Andea AA; Patel RM; Lowe L; Fullen DR; Brown NA; Tomlins SA; Udager AM; Harms PW
Mod Pathol; 2020 Jun; 33(6):1092-1103. PubMed ID: 31857679
[TBL] [Abstract][Full Text] [Related]
24. Upregulated MYC expression and p53 mutations may contribute to the oncogenesis of canine Meibomian gland carcinomas.
Peterson C; Hicks JL; De Marzo AM; Campbell AA; Eberhart CG; Dubielzig RR; Teixeira LB
Vet Pathol; 2023 Mar; 60(2):185-189. PubMed ID: 36541627
[TBL] [Abstract][Full Text] [Related]
25. Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma.
Zilberg C; Lee MW; Yu B; Ashford B; Kraitsek S; Ranson M; Shannon K; Cowley M; Iyer NG; Palme CE; Ch'ng S; Low TH; O'Toole S; Clark JR; Gupta R
Mod Pathol; 2018 Feb; 31(2):275-287. PubMed ID: 28984303
[TBL] [Abstract][Full Text] [Related]
26. Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation.
Fiorentino FP; Tokgün E; Solé-Sánchez S; Giampaolo S; Tokgün O; Jauset T; Kohno T; Perucho M; Soucek L; Yokota J
Oncotarget; 2016 May; 7(21):31014-28. PubMed ID: 27105536
[TBL] [Abstract][Full Text] [Related]
27. Circumscribed sebaceous neoplasms: a morphological, immunohistochemical and molecular analysis.
Harvey NT; Tabone T; Erber W; Wood BA
Pathology; 2016 Aug; 48(5):454-62. PubMed ID: 27311873
[TBL] [Abstract][Full Text] [Related]
28. Distinct Genomic Alterations in Prostate Tumors Derived from African American Men.
Liu W; Zheng SL; Na R; Wei L; Sun J; Gallagher J; Wei J; Resurreccion WK; Ernst S; Sfanos KS; Isaacs WB; Xu J
Mol Cancer Res; 2020 Dec; 18(12):1815-1824. PubMed ID: 33115829
[TBL] [Abstract][Full Text] [Related]
29. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y
Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892
[TBL] [Abstract][Full Text] [Related]
30. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
[TBL] [Abstract][Full Text] [Related]
31. Next-generation sequencing of salivary high-grade neuroendocrine carcinomas identifies alterations in RB1 and the mTOR pathway.
Goyal B; Duncavage EJ; Martinez D; Lewis JS; Chernock RD
Exp Mol Pathol; 2014 Dec; 97(3):572-8. PubMed ID: 25446844
[TBL] [Abstract][Full Text] [Related]
32. HPV51-associated Leiomyosarcoma: A Novel Class of TP53/RB1-Wildtype Tumor With Predilection for the Female Lower Reproductive Tract.
Williams EA; Montesion M; Lincoln V; Tse JY; Hiemenz MC; Mata DA; Shah BB; Shoroye A; Alexander BM; Werth AJ; Foley-Peres K; Milante RR; Ross JS; Ramkissoon SH; Williams KJ; Adhikari LJ; Zuna RE; LeBoit PE; Lin DI; Elvin JA
Am J Surg Pathol; 2022 Jun; 46(6):729-741. PubMed ID: 35034043
[TBL] [Abstract][Full Text] [Related]
33. Genomic profiling reveals the pivotal role of hrHPV driving copy number and gene expression alterations, including mRNA downregulation of TP53 and RB1 in penile cancer.
Macedo J; Silva E; Nogueira L; Coelho R; da Silva J; Dos Santos A; Teixeira-Júnior AA; Belfort M; Silva G; Khayat A; de Oliveira E; Dos Santos AP; Cavalli LR; Pereira SR
Mol Carcinog; 2020 Jun; 59(6):604-617. PubMed ID: 32212199
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.
Cani AK; Soliman M; Hovelson DH; Liu CJ; McDaniel AS; Haller MJ; Bratley JV; Rahrig SE; Li Q; Briceño CA; Tomlins SA; Rao RC
Mod Pathol; 2016 Jul; 29(7):685-97. PubMed ID: 27102345
[TBL] [Abstract][Full Text] [Related]
36. Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes.
Offin M; Chan JM; Tenet M; Rizvi HA; Shen R; Riely GJ; Rekhtman N; Daneshbod Y; Quintanal-Villalonga A; Penson A; Hellmann MD; Arcila ME; Ladanyi M; Pe'er D; Kris MG; Rudin CM; Yu HA
J Thorac Oncol; 2019 Oct; 14(10):1784-1793. PubMed ID: 31228622
[TBL] [Abstract][Full Text] [Related]
37. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.
Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR
BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468
[TBL] [Abstract][Full Text] [Related]
38. Molecular alterations in retinoblastoma beyond RB1.
Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
[TBL] [Abstract][Full Text] [Related]
39. Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous?
Nakayama T; Ling ZQ; Mukaisho K; Hattori T; Sugihara H
BMC Cancer; 2010 Jun; 10():311. PubMed ID: 20565940
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma.
Ohmoto A; Sato Y; Asaka R; Fukuda N; Wang X; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Toshiyasu T; Mitani H; Takeuchi K; Mori S; Takahashi S
Mod Pathol; 2021 Nov; 34(11):1979-1989. PubMed ID: 34247193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
